2-Methyl-2-propanyl 3-amino-9-azabicyclo[3.3.1]nonane-9-carboxylate(CAS: 202797-03-3)

This compound must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for hazardous substances. In Europe, it is subject to the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. In the USA, the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have specific guidelines for its handling and storage. Detailed documentation and safety data sheets (SDS) are required for proper management and compliance.

Alternatives to this compound in synthesis include using similar 3-amino-9-azabicyclo[3.3.1]nonane derivatives with different substituents. Common reagents like substituted amine or carboxylic acids can be used as substitutes. Additionally, isomers such as 3-aminocycloheptanecarboxylic acid or other 3-amino-9-azabicyclo compounds may serve as viable alternatives depending on the specific application.

Research in this compound is currently focusing on its application in pharmaceuticals and biotechnology, particularly in drug development. Market trends indicate increasing demand for this compound due to its unique structural properties. Emerging research fields include its use as a precursor in the synthesis of complex organic molecules and in medicinal chemistry applications.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste treatment facilities. Incineration is a common method for disposal, but it must be conducted under controlled conditions to minimize environmental impact. Proper environmental protection measures, such as containment and monitoring, are essential to ensure compliance with local and international regulations.